Patents-Review.com
🔗 Permalink
Assignee profile:

GENMAB A/S

City:

Valby

Country:

Denmark

Published Applications:

23

Last publication date:

2025-01-02

Patent Grants:

23

Last grant date:

2025-07-08

Top Inventors for applications by GENMAB A/S

These are the the leading inventors for applications assigned to GENMAB A/S:

Recent patent applications by GENMAB A/S

GENMAB A/S based in Valby, DK has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2025-01-02 ✅ Patent 12,351,650 granted on 2025-07-08
US20250002610A1
Chemistry; metallurgy

ANTIBODIES BINDING TO FIBROBLAST ACTIVATION PROTEIN ALPHA AND DEATH RECEPTOR 4

 #2 | 2024-08-01 ✅ Patent 12,421,319 granted on 2025-09-23
US20240254249A1
Chemistry; metallurgy

AGONISTIC TNF RECEPTOR BINDING AGENTS

 #3 | 2024-03-21 ✅ Patent 12,589,150 granted on 2026-03-31
US20240091352A1
Human necessities

ANTIBODIES BINDING AXL

 #4 | 2023-09-21 ✅ Patent 12,398,214 granted on 2025-08-26
US20230295335A1
Chemistry; metallurgy

BINDING AGENTS BINDING TO EPCAM AND CD137

 #5 | 2023-04-27 ✅ Patent 11,814,437 granted on 2023-11-14
US20230132049A1
Chemistry; metallurgy

Antibodies binding to CD30 and CD3

 #6 | 2023-01-26 ✅ Patent 12,617,854 granted on 2026-05-05
US20230027394A1
Chemistry; metallurgy

HUMANIZED OR CHIMERIC CD3 ANTIBODIES

 #7 | 2022-04-21 ✅ Patent 11,845,805 granted on 2023-12-19
US20220119544A1
Chemistry; metallurgy

Bispecific antibody against CD3 and CD20 in combination therapy for treating diffuse large B-cell lymphoma

 #8 | 2022-04-14 ✅ Patent 11,858,995 granted on 2024-01-02
US20220112287A1
Chemistry; metallurgy

Bispecific antibodies against CD3 and CD20 for treating chronic lymphocytic leukemia

 #9 | 2022-03-24 ✅ Patent 12,324,841 granted on 2025-06-10
US20220088191A1
Human necessities

METHODS OF TREATING CANCER WITH A COMBINATION OF AN ANTI-PD-1 ANTIBODY AND AN ANTI-TISSUE FACTOR ANTIBODY-DRUG CONJUGATE

 #10 | 2022-03-03 ✅ Patent 11,939,388 granted on 2024-03-26
US20220064317A1
Chemistry; metallurgy

Multispecific antibodies against CD40 and CD137

 #11 | 2022-02-17 ✅ Patent 11,970,544 granted on 2024-04-30
US20220049013A1
Chemistry; metallurgy

Antibodies

 #12 | 2022-02-03 ✅ Patent 12,077,596 granted on 2024-09-03
US20220033510A1
Chemistry; metallurgy

Multispecific antibodies against CD40 and CD137

 #13 | 2021-12-30 ✅ Patent 12,453,781 granted on 2025-10-28
US20210402003A1
Human necessities

METHODS OF TREATING CANCER WITH A COMBINATION OF AN ANTI-VEGF ANTIBODY AND AN ANTI-TISSUE FACTOR ANTIBODY-DRUG CONJUGATE

 #14 | 2021-12-02 ✅ Patent 12,435,154 granted on 2025-10-07
US20210371538A1
Chemistry; metallurgy

BISPECIFIC ANTIBODIES AGAINST CD3 AND CD20

 #15 | 2021-09-09 ✅ Patent 12,637,515 granted on 2026-05-26
US20210277133A1
Chemistry; metallurgy

BINDING AGENTS BINDING TO PD-L1 AND CD137 AND USE THEREOF

 #16 | 2021-09-02 ✅ Patent 12,570,751 granted on 2026-03-10
US20210269541A1
Chemistry; metallurgy

BINDING AGENTS BINDING TO PD-L1 AND CD137 AND USE THEREOF

 #17 | 2021-09-02 ✅ Patent 12,247,065 granted on 2025-03-11
US20210269509A1
Chemistry; metallurgy

Method for producing a controlled mixture of two or more different antibodies

 #18 | 2021-01-21 ✅ Patent 12,246,025 granted on 2025-03-11
US20210015939A1
Human necessities

Methods of treating cancer with a combination of a platinum-based agent and an anti-tissue factor antibody-drug conjugate

 #19 | 2020-08-20 ✅ Patent 11,866,514 granted on 2024-01-09
US20200262932A1
Chemistry; metallurgy

Heterodimeric antibody Fc-containing proteins and methods for production thereof

 #20 | 2020-06-18 ✅ Patent 12,415,859 granted on 2025-09-16
US20200190200A1
Chemistry; metallurgy

Methods of Producing Heterodimeric Antibodies

 #21 | 2020-04-30 ✅ Patent 11,795,214 granted on 2023-10-24
US20200131253A1
Chemistry; metallurgy

Modulation of complement-dependent cytotoxicity through modifications of the C-terminus of antibody heavy chains

 #22 | 2019-01-31 ✅ Patent 12,115,227 granted on 2024-10-15
US20190030180A1
Human necessities

Formulation for antibody and drug conjugate thereof

 #23 | 2018-07-19 ✅ Patent 12,595,316 granted on 2026-04-07
US20180201693A1
Chemistry; metallurgy

BISPECIFIC AND MULTISPECIFIC ANTIBODIES AND METHOD FOR ISOLATION OF SUCH

Also check out GENMAB A/S's (Valby, Denmark) applicant profile with 62 patent applications submitted.

AssigneeID:

349028 ⎘